Deals
Takeda Shares Fall Most Since 2009 on Possible Bid for Shire
- Shire says it hasn’t received a formal approach or offer
- Takeda says no certainty it will make an approach for Shire
This article is for subscribers only.
Shares of Takeda Pharmaceutical Co. fell the most in nine years after disclosing it is considering a bid for Shire Plc that could approach $50 billion, which would be the Japanese company’s biggest takeover ever.
The stock decline shaved more than $3 billion from Takeda’s market cap. Coupled with a rally in Shire’s stock on the news Wednesday, the valuation gap between the two companies widened by more than $6.5 billion, posing a bigger financial challenge for Takeda if it decides to go forward with an offer.